| ID | Name | CAS | Properties |
logPoct/wat |
| 50-836-8 |
3«alpha»,16«alpha»-dihydroxy-5«alpha»-androstan-17-one, MO-TMS, (syn,anti)
|
|
2 | 8.287 |
| 50-844-9 |
Indeno[1,2-c]pyrazol-4-one, 7-chloro-3-propyl-, hydrazone
|
116434-72-1 |
2 | 2.225 |
| 50-892-6 |
[1,2,5]Thiadiazolo[3,4-d]pyrimidine, 7-(hydroxyamino)-
|
|
2 | 0.282 |
| 50-956-5 |
N6-(cyclotetramethylene-tertbutylsilyl)-Adenosine, 2',3',5'-tris-O-TBDMS
|
|
2 | 10.478 |
| 50-997-0 |
3-«alpha»,6-«alpha»,12-«alpha»-Trihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
2 | 9.115 |
| 51-026-6 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,17-O)-diTMTBSi, (20-O)-TMSi
|
|
2 | 12.139 |
| 51-081-5 |
4-Imidazole carboxamide,5-(3-methyl-3-pentyl-1-triazeno)-
|
18910-61-7 |
2 | 1.147 |
| 51-093-2 |
(E/Z)-3«beta»-Acetoxytrimethylsilyloxylup-20(29)-ene, # 1
|
|
2 | 9.775 |
| 51-193-1 |
Oxime of 5-acetyl-4-methyl-4-thiazoline-2-thione
|
|
2 | 1.830 |
| 51-228-2 |
7«alpha»-hydroxy-3-oxo-4-cholesten-26-oate, oxime-TMS
|
|
2 | 11.158 |
| 51-368-7 |
16«alpha», 17-H2-17-OH GA20 methyl ester TMS ether
|
|
2 | 5.139 |
| 51-446-0 |
3«beta»,7«alpha»-Dihydroxy-4-cholenic acid, methyl ester, TMS
|
|
2 | 8.205 |
| 51-494-7 |
9-Dodecyn-1-ol, dimethyl(dimethyl(pyrid-2-ylmethoxy)silyloxy)silyl ether
|
|
2 | 6.179 |
| 51-500-9 |
2,3,10,11-Tetrahydrobenzo[b]dipyrido[3,2,1-de:1,2,3-mn]-phenazine-1,12-dione
|
|
2 | 4.602 |
| 51-595-5 |
Ribonic acid, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, trimethylsilyl ester
|
57197-35-0 |
2 | 5.876 |
| 51-618-9 |
3«alpha»,5«beta»,7«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, TMS
|
|
2 | 10.464 |
| 51-817-8 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»,21-triol, methylboronate, TMS
|
|
2 | 6.543 |
| 52-107-5 |
9,10-Anthracenedione, 3-methyl-1,6,8-tris[(trimethylsilyl)oxy]-
|
7336-74-5 |
2 | 6.412 |
| 52-316-3 |
17-«alpha»-Hydroxy-17-«beta»-methyl-5-«beta»-androstan-3-one, per-TMS
|
|
2 | 7.985 |
| 52-337-0 |
D-Mannitol, 1,2,3,4,5,6-hexakis-O-(trimethylsilyl)-
|
14317-07-8 |
2 | 7.570 |
| 52-371-2 |
(3R,4S)-4-tert-butyldimethylsilyloxy-1-tert-butoxycarbonyl-3-hydroxyazepane
|
|
2 | 3.769 |
| 52-375-8 |
5.beta.-pregn-7-ene-3.alpha.,17.alpha.,20.alpha.-triol
|
|
2 | 9.000 |
| 52-464-9 |
D-Gluconic acid, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, trimethylsilyl ester
|
34290-52-3 |
2 | 7.096 |
| 52-470-2 |
L-Cystine, N,N1-bis(tert-butyldimethylsilyl)-, bis(tert-butyldimethylsilyl) ester
|
|
2 | 9.391 |
| 52-523-3 |
Propanoic acid, 2-methyl-2,3-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
38166-00-6 |
2 | 3.826 |
| 52-568-4 |
4-(2-tert-Butyldimethylsilylamino-1-t-butyldimethylsilyloxyethyl)phenol, tert-butyldimethylsilyl ether
|
|
2 | 8.728 |
| 52-626-9 |
Urea, 1-methyl-1-nitroso-3-[(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)methyl-
|
|
2 | -2.078 |
| 52-740-2 |
4-(7-Ethyl-3-methyl-5-propenyl-2,3-dihydro-benzofuran-2-yl)-2,6-dimethoxy-phenol, TES
|
|
2 | 7.921 |
| 52-770-9 |
tert-Butyl-[2-[2-[2-[2-[2-[2-[2-[2-(tert-butyldimethylsilyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]dimethylsilane
|
|
2 | 5.146 |
| 52-777-2 |
6.alpha.,17.beta.-Dihydroxy-5.alpha.-androstan-3-one, TMS
|
|
2 | 8.424 |
| 52-783-5 |
3-HYDROXY-3-(4'-HYDROXY-3'-METHOXYPHENYL)PROPIONIC ACID TRITMS
|
|
2 | 5.570 |
| 52-792-5 |
Selenoethionine, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
2 | 2.640 |
| 52-797-0 |
1,5,7-Trimethyl-2-nitro-imidazo[4,5,d]pyrimidin-4,6-dione
|
|
2 | -1.121 |
| 52-801-4 |
5-Cholesten-3-.beta.,27-diol-17,22-dione, TMS
|
|
2 | 12.278 |
| 52-880-7 |
5«beta»-Androstan-7«alpha»,17«alpha»-dimethyl-3«alpha»,17«beta»-diol, TMS
|
|
2 | 8.105 |
| 52-884-3 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, methylboronate
|
|
2 | 3.788 |
| 52-917-6 |
L-Serine, N,O-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
107715-93-5 |
2 | 6.520 |
| 53-065-1 |
Silane, diphenylpentyloxy(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 4.792 |
| 53-082-2 |
(E)-10-Dodecenoic acid, 9,12-dioxo, methyl ester, «omega»-PFB-oxime, TMS-enol, # 1
|
|
2 | 6.690 |
| 53-090-3 |
3«alpha»,5«beta»,7«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 12.024 |
| 53-122-7 |
Benzaldehyde, 2-hydroxy, 3-nitro-5-tert.-octyl, oxime, TMS
|
|
2 | 5.291 |
| 53-127-2 |
2-Deoxy-D-ribose, tris(trimethylsilyl) ether, trimethylsilyloxime (isomer 2)
|
|
2 | 5.505 |
| 53-163-2 |
4-ISOPROPYL-2,6,7-TRIOXA-1-PHOSPHABICYCLO[2.2.2]OCTANE 1-OXIDE
|
|
2 | 1.814 |
| 53-178-6 |
Naphtho[2,3-d]-1,2,3-triazin-4(3H)-one, 3-phenyl-
|
|
2 | 2.934 |
| 53-406-2 |
5«alpha»-Pregnan-3«beta»,20«beta»-diol, allyl-DMS
|
|
2 | 8.828 |
| 53-458-5 |
3«alpha»,5«beta»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 10.804 |
| 53-489-1 |
Glycine, N-(2-methyl-1-oxo-2-propenyl)-N-(trimethylsilyl)-, trimethylsilyl ester
|
55557-27-2 |
2 | 2.604 |
| 53-502-5 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«alpha»-diol, bisTBDMS
|
|
2 | 9.666 |
| 53-635-8 |
(3R,4S)-3-Azido-4-tert-butyldimethylsilyloxy-1-tert-butoxycarbonylazepane
|
|
2 | 5.087 |
| 53-644-8 |
2-Amino-3,5,7,8-tetrahydro-4,6-pteridinedione
|
1011-23-0 |
2 | -1.766 |
| 53-712-2 |
4-(tert-Butylamino)-6-ethyl-6-trimethylsilylamino-5H-1,3,5-triazin-2-one
|
|
2 | 1.555 |
| 53-737-5 |
5«beta»-Androst-1-ene-3«alpha»,17«alpha»-diol, per-TMS
|
|
2 | 7.245 |
| 53-771-7 |
N-tert-Butyl-N'-tert-butyldimethylsilyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
|
2 | 3.508 |
| 53-789-8 |
Androst-1,4-dien-17«beta»-ol-3-one, TMS
|
|
2 | 7.291 |
| 53-903-0 |
4-Pregnen-20-«alpha»-ol-3,11-dione, MO-TMS
|
|
2 | 6.420 |
| 53-929-2 |
5-«beta»-Pregnan-3-«alpha»-ol-11,20-dione, MO-TMS
|
|
2 | 6.500 |
| 54-056-0 |
2,2,4,6,8-pentamethyl-4,6,8-tri(2-cyanoethyl)-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 3.725 |
| 54-070-4 |
Thiazolo[5,4-d]pyrimidine, 5-amino-2-[(2-chloroethyl)thio]-7-(ethylamino)-
|
|
2 | 2.431 |
| 54-118-1 |
2,2,4,4,6-pentamethyl-6-(2-cyanoethyl)-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 2.439 |
| 54-340-4 |
2,6-Dihydroxybenzoic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
2 | 8.617 |
| 54-432-2 |
5«beta»-Pregnane-3«alpha»,11«beta»,20«alpha»-triol, EO-TMS
|
|
2 | 8.545 |
| 54-472-8 |
3-«beta»,7-«alpha»,12-«alpha»-Trihydroxy-5-cholenoic acid, methyl ester, TMS
|
|
2 | 9.035 |
| 54-567-3 |
3«alpha»,15«alpha»-dihydroxy-5«beta»-androstan-17-one, TMS
|
|
2 | 8.424 |
| 54-619-5 |
3-«beta»,7-«alpha»,12-«alpha»-Trihydroxy-4-cholenoic acid, methyl ester, TMS
|
|
2 | 9.035 |
| 54-675-3 |
Benzoic acid, 2-(3-butyl-3-methyl-1-triazeno)-, hydrazide
|
116466-08-1 |
2 | 2.021 |
| 54-724-8 |
5«beta»-Pregnane-3«beta»,17«alpha»-diol-20-one, MO TMS
|
|
2 | 7.862 |
| 54-882-3 |
Trimethylsilyl (2Z)-4-methyl-2-[(trimethylsilyl)oxy]pent-2-enoate
|
|
2 | 3.756 |
| 54-925-5 |
Benzaldehyde, 2-hydroxy, 3-chloro-5-tert.-butyl, oxime, TMS
|
|
2 | 6.037 |
| 54-939-0 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«alpha»-diol, bisTMIPS
|
|
2 | 9.954 |
| 55-150-4 |
N6-(cyclotetramethylene-tertbutylsilyl)-2'-Deoxyadenosine, 3',5'-bis-O-TBDMS
|
|
2 | 8.477 |
| 55-182-9 |
3-Acetyl-5-methylmercapto-1,3,4-thiadiazolidone-2-azine
|
109967-13-7 |
2 | 1.383 |
| 55-306-1 |
3-(Pyrrol[3-(1-ethylbutoxy)-1,1,3,3-tetramethyldisiloxanyl]oxymorphomethyl)pyridine
|
|
2 | 4.614 |
| 55-339-5 |
R,S-3',4'-methylenedioxy-«alpha»-pyrrolidinopropiophenone-M ((dihydro-), TMS
|
|
2 | 3.792 |
| 55-354-8 |
Caffeic acid, O,O'-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
180715-88-2 |
2 | 9.016 |
| 55-413-2 |
7«beta»,16«alpha»,17-triOH-kauranoic acid, methyl ester TMS ether
|
|
2 | 7.844 |
| 55-435-8 |
16«beta», 17-H2-17-OH GA20 methyl ester TMS ether
|
|
2 | 5.139 |
| 55-472-7 |
Urea, N-(2-chloroethyl)-N'-(2,6-dioxo-3-piperidinyl)-N-nitroso-
|
13909-02-9 |
2 | -0.277 |
| 55-613-0 |
7«alpha»,12«alpha»-dihydroxy, 3-oxy-4-cholenoate, methyl ester-trimethylsilyl ether
|
|
2 | 9.160 |
| 55-638-3 |
3A,17A,21-Trihydroxy-5B-pregnan-20-one, MO TMS
|
|
2 | 8.693 |
| 55-651-8 |
N6-TFA-2'-Deoxyadenosine, 3'-O-TFA, 5'-O-TBDMS
|
|
2 | 4.111 |
| 55-684-2 |
2-(N-tert-Butyldimethylsilyl)amino-4-methylphenol tert-butyldimethylsilyl ether
|
|
2 | 6.796 |
| 55-706-7 |
Benzaldehyde, 2-hydroxy, 3-chloro-5-tert.-octyl, oxime, TMS
|
|
2 | 7.453 |
| 55-759-9 |
2(1H)-Pyrimidinone, 1-[2,3-bis-O-(trimethylsilyl)-«beta»-D-ribofuranosyl]-4-(trimethylsiloxy)-, 5'-[bis(trimethylsilyl) phosphate]
|
32645-59-3 |
2 | 6.622 |
| 55-791-3 |
Silane, dimethyl(dimethyl(but-3-enyloxy)silyloxy)(but-3-enyloxy)-
|
|
2 | 3.592 |
| 55-961-4 |
17-«beta»-Hydroxy-17-«alpha»-methyl-5-«beta»-androst-1-en-3-one, 17-TMS
|
|
2 | 5.984 |
| 55-992-0 |
Pregnan-20-one, 3,11,21-tris[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»,11«beta»)-
|
56196-42-0 |
2 | 8.116 |
| 56-029-8 |
(E/Z)-3.beta.,29-bis-(Trimethylsilyloxy)lup-20(29)-ene, # 2
|
|
2 | 11.063 |
| 56-075-7 |
2,2,4,4,6,6-hexamethyl-8,8,10,10-tetraphenyl-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 4.702 |
| 56-110-7 |
5.alpha.-Androst-2-en-3,17.beta.-diol, (3,17-O-)-diTBDMSi
|
|
2 | 9.935 |
| 56-122-4 |
3A,11B,17A,21-Tetrahydroxy-5B-pregnan-20-one, enol, tetrakis-TMS
|
|
2 | 9.355 |
| 56-200-7 |
N-(3-Bromo-4-hydroxy-phenyl)-4-nitro-benzenesulfonamide, N,O-di(tert.-butydiimethylsilyl)-
|
|
2 | 7.942 |
| 56-206-1 |
15(S)-15-Methyl-PGA2, MO-TMS, isomer # 1
|
|
2 | 8.032 |
| 56-340-2 |
«alpha»-D-Mannopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)-
|
24707-99-1 |
2 | 6.075 |
| 56-378-1 |
3A,17A,21-Trihydroxy-5A-pregnan-20-one, MO TMS
|
|
2 | 8.693 |
| 56-435-7 |
4-Aminobenzoic acid, N- acetyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 6.207 |
| 56-461-8 |
4-(7-Ethyl-3-methyl-5-propenyl-2,3-dihydro-benzofuran-2-yl)-2-methoxy-phenol, TMS
|
|
2 | 6.742 |
| 56-481-6 |
Nicotinic acid, 6-[n-[(2-acetamido-3-hydro-4-oxo-6-pteridinyl)methyl]acetamido]
|
30958-64-6 |
2 | -0.164 |
| 56-520-2 |
L-Lysine, N2,N6-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
107715-99-1 |
2 | 7.263 |
| 56-565-3 |
5-Pregnen-3-.beta.,15-.beta.,17-.alpha.,20-.alpha.-tetrol, TMS
|
|
2 | 9.830 |
| 56-575-2 |
Indole, 3-(2-acetaminoethyl), 6-hydroxy-5-methoxy (Hydroxymelatonin), TMS
|
|
2 | 4.225 |
|
« Previous Results
Next Results »
|